| scholarly article | Q13442814 |
| P50 | author | Lynne Mofenson | Q43882680 |
| William T. Shearer | Q45453692 | ||
| P2093 | author name string | Fowler MG | |
| Stiehm ER | |||
| Burchett S | |||
| Hawkins E | |||
| Sloand EM | |||
| Kang M | |||
| Bryson YJ | |||
| Fenton T | |||
| Starr SE | |||
| Palumbo PE | |||
| Fletcher CV | |||
| Wara D | |||
| Nemo GJ | |||
| Sapan CV | |||
| Petru A | |||
| Meyer WA | |||
| Bouquin P | |||
| Purdue L | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 548-554 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273). | |
| P478 | volume | 181 |
| Q36198648 | Clinical experience with therapeutic AIDS vaccines |
| Q40377124 | Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses |
| Q33843554 | Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. |
| Q24550699 | Passive immunity in prevention and treatment of infectious diseases |
| Q53514004 | Randomized controlled trial of short-term withdrawal of i.v. immunoglobulin therapy for selected children with human immunodeficiency virus infection. |
| Q38764543 | Use of broadly neutralizing antibodies for HIV-1 prevention |
| Q30145641 | Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role |
Search more.